Allergan Announces FDA Approval of Label Extensions for JUVEDERM Ultra and JUVEDERM Ultra Plus IRVINE, Calif. -- Allergan, Inc., the maker of BOTOX® Cosmetic (Botulinum Toxin Type A), today announced ...

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX(R) Cosmetic (Botulinum Toxin Type A), today announced it is launching its 'next-generation' hyaluronic acid dermal filler ...

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX ® Cosmetic (Botulinum Toxin Type A), today announced nationwide availability of its ‘next-generation’ hyaluronic acid ...

Hyaluronic acid 24mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to initiation. Avoid ...

Hyaluronic acid 24mg/mL; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to initiation. Avoid ...

TORONTO, ON--(Marketwired - Oct 29, 2014) - Allergan Canada, in partnership with ModiFace Inc., is delighted to announce the launch of the Juvéderm ® Visualizer 3D iPad application. For the first time ...

IRVINE, Calif., Aug. 1, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the first ever JUVÉDERM® Day on Wednesday, August 16, 2023. The celebration recognizes the ...

Juvéderm is a dermal filler used for the treatment of facial wrinkles. It contains both water and hyaluronic acid to create a gel-like product that plumps up your skin. The national average cost for ...

Both treatments may cause mild, temporary side effects such as swelling or bruising. Some of the more serious side effects include infection, stroke, and blindness. Radiesse and Juvéderm are ...